Effects of calcitriol and its analogues, calcipotriol (MC 903) and 20- epi-1α,25-dihydroxyvitamin D3 (MC 1288), on calcium influx and DNA synthesis in cultured muscle cells

Biochemical Pharmacology

Volumn 53, Issue 12, 1997, Pages 1807-1814

  Selles, Juana ^a   Massheimer, Virginia ^a   Santillan, Graciela ^a   Marinissen, Maria Julia ^a   Boland, Ricardo ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

Calcium channels; DNA synthesis; Intestine; Muscle; Non genomic effects; Vitamin D analogues

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; CALCIUM CHANNEL; LEXACALCITOL; NIFEDIPINE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCIUM METABOLISM; CALCIUM TRANSPORT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHICK EMBRYO; CONCENTRATION RESPONSE; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; DRUG ANTAGONISM; EMBRYO; HEART MUSCLE CELL; INTESTINE CELL; MUSCLE CELL; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

EID: 0030786516     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)82445-8     Document Type: Article

References (52)

1. Minghetti PP and Norman AW, Vitamin D receptors: Gene regulation and genetic circuitry. FASEB J 2: 3043-3053, 1988.
2. de Boland AR and Nemere I, Rapid actions of vitamin D compounds. J Cell Biochem 49: 32-36, 1992.
3. 3 metabolites modulate dihydropyridine calcium currents in clonal rat osteosarcoma cells. J Biol Chem 264: 20265-20274, 1989.
4. 3-mediated rapid stimulation of intestinal calcium transport, (transcaltachia). Endocrinology 127: 39-45, 1990.
5. 3 in cardiac muscle. Mol Cell Endocrinol 82: 229-235, 1991.
6. 3 on the phosphoinositide metabolism in rat enterocytes. J Biol Chem 264: 20403-20406, 1989.
7. 3. Biochem J 289: 675-679, 1993.
8. Nemere I and Norman AW, At the cutting edge. Steroid hormone actions at the plasma membrane: Induced calcium uptake and exocytosis. Mol Cell Endocrinol 80: c165-c169, 1991.
9. 3 are suppressed by calcium channel blockers. Endocrinology 120: 1858-1864, 1987.
10. 2+ exchange. Endocrinology 124: 2765-2775, 1989.
11. 2+ transport in chick perfused duodenum. Biochem Biophys Res Commun 166: 217-222, 1990.
12. 3. Mol Cell Endocrinol 77: 67-73, 1991.
13. 3. Kidney Int 38: S9-S16, 1990.
14. Binderup L, Immunological properties of vitamin D analogues and metabolites. Biochem Pharmocol 43: 1885-1892, 1992.
15. 3 in the myeloid cell differentiation. Proc Soc Exp Biol Med 191: 214-220, 1989.
16. Bikkle DD and Pillai S, Vitamin D, calcium, and epidermal differentiation. Endocr Rev 14: 3-19, 1993.
17. 3 and its fluorinated analogs. Cancer Res 44: 5624-5628, 1984.
18. Boland R, The role of vitamin D in skeletal muscle function. Endocr Rev 7: 434-448, 1986.
19. Brown A, Finch J, Lopez-Hilker S, Dusso A, Ritter C, Pernalete N and Slatopolsky E, New active analogues of vitamin D with low calcémic activity. Kidney Int 38: 22-27, 1990.
20. Jones G and Calverley MJ, A dialogue on analogues: Newer vitamin D-drugs for use in bone disease, psoriasis and cancer. Trends Endocrinol Metab 4: 297-303, 1993.
21. 3 and the skin: A unique application for the treatment of psoriasis. Proc Soc Exp Biol Med 191: 246-262, 1989.
22. Kragballe K, Gjertsen BT, de Hoop D, Karlsmark T, van de Kerkhof PCM, Larkö O, Nieboer C, Roed-Petersen J, Strand A and Tikjøb G, Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 337: 193-196, 1991.
23. Van de Kerkhof PCM, Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol 132: 675-682, 1995.
24. Coombes RC, New targets for cancer therapy. Mol Aspects Med 14: 373-449, 1993.
25. 3 analogs and their potential for inhibiting cell growth. Drugs Future 18: 1057-1061, 1993.
26. Slatopolsky E, Berkoben M, Kellber J, Brown A and Delmez J, Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism. Kidney Int 42: S43-S49, 1992.
27. Bouillion R, Allewaert K, Xiang D, Tan B and Van Baelen H, Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activity. J Bone Miner Res 5: 1051-1057, 1991.
28. Pols HA, Birkenhäger JC and van Leeuwen JPTM, Vitamin D analogues: From molecule to clinical application. Clin Endocrinol 40: 285-291, 1994.
29. 3 in rat osteosarcoma cells: Structure-function studies using ligand analogs. Endocrinology 129: 1876-1884, 1991.
30. i in Caco-2 cells. Am J Physiol 265: G143-G148, 1993.
31. 3. J Biol Chem 268: 20022-20030, 1993.
32. 3 in osteosarcoma cells is independent of calcium influx. Endocrinology 135: 2446-2453, 1994.
33. Bouillon R, Okamura WH and Norman AW, Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16: 200-257, 1995.
34. 3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Commun 128: 305-309, 1985.
35. 3 receptors identified in the rat heart. J Mol Cell Cardiol 18: 67-72, 1986.
36. de Boland AR and Boland R, Non-genomic signal transduction pathway of vitamin D in muscle. Cell Signal 6: 717-724, 1994.
37. 3. Biochim Biophys Acta 1014: 112-119, 1989.
38. 3. Mol Cell Endocrinol 90: 231-238, 1993.
39. 3. Mol Cell Endocrinol 114: 1-8, 1995.
40. 3 stimulation of calcium uptake by rat intestinal cells involves a dihydropyridine-sensitive cAMP-dependent pathway. Cell Signed 6: 299-304, 1994.
41. 3 metabolites on calcium fluxes in intact chicken skeletal muscle and myoblasts cultured in vitro. Calcif Tissue Int 36: 200-205, 1984.
42. 3. J MoL Cell Cordial 26: 1593-1599, 1994.
43. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
44. 2+ channel in rat heart cells by dihydropyridine derivatives. Biochem Biophys Res Commun 126: 405-412, 1984.
45. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
46. 3. Biochem Mol Biol Int 31: 677-684, 1993.
47. Reuter H, Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 301: 569-574, 1983.
48. Binderup L and Kragballe K, Origin of the use of calcipotriol in psoriasis treatment. Rev Contemp Pharmacother 3: 357-365, 1992.
49. 3 analogues: A novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42: 1569-1575, 1991.
50. 2+ entry-stimulating pathways. Am J Physiol 265: F705-F711, 1993.
51. 2+ entry: Toward a proliferation or a simplification. FASEB J 6: 3085-3091, 1992.
52. Berridge MJ, Inositol trisphosphate and calcium signalling. Nature 361: 315-325, 1989.